Sandoz Group AG (LON:0SAN)
London
· Delayed Price · Currency is GBP · Price in CHF 37.68
+0.77 (2.09%)
At close: May 8, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Generics | 6.61B |
Log In |
Log In |
Log In |
Log In |
| Generics Growth | -1.05% |
Log In |
Log In |
Log In |
Log In |
| Biosimilars | 2.51B |
Log In |
Log In |
Log In |
Log In |
| Biosimilars Growth | 26.23% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Europe | 3.18B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 3.50% |
Log In |
Log In |
Log In |
Log In |
| International | 2.25B |
Log In |
Log In |
Log In |
Log In |
| International Growth | 0.43% |
Log In |
Log In |
Log In |
Log In |
| United States | 1.67B |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 14.73% |
Log In |
Log In |
Log In |
Log In |
| Germany | 1.15B |
Log In |
Log In |
Log In |
Log In |
| Germany Growth | 3.53% |
Log In |
Log In |
Log In |
Log In |
| North America | 479.08M |
Log In |
Log In |
Log In |
Log In |
| North America Growth | 4.12% |
Log In |
Log In |
Log In |
Log In |
| Switzerland | 388.37M |
Log In |
Log In |
Log In |
Log In |
| Switzerland Growth | 19.06% |
Log In |
Log In |
Log In |
Log In |
| France | - |
Log In |
Log In |
Log In |
Log In |
| France Growth | - |
Log In |
Log In |
Log In |
Log In |
| Canada | - |
Log In |
Log In |
Log In |
Log In |
| Canada Growth | - |
Log In |
Log In |
Log In |
Log In |
| Italy | - |
Log In |
Log In |
Log In |
Log In |
| Italy Growth | - |
Log In |
Log In |
Log In |
Log In |
| Austria | - |
Log In |
Log In |
Log In |
Log In |
| Austria Growth | - |
Log In |
Log In |
Log In |
Log In |